Invention Patent AGENTES TERAPÊUTICOS DIRECIONADOS AO RECEPTOR DE SOMATOSTATINA SUBTIPO 2 (SST2R) E USOS DOS MESMOS de CRINETICS PHARMACEUTICALS, INC. — IPC A61K 31/4468. Drawing published by the INPI in the Industrial Property Gazette.
Examination has not been requested yet. Without that request by 12/11/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:12/11/2026(108 days left)
Latest action published by the INPI: 02/24/2026. We update with every new RPI gazette, published weekly.
AGENTES TERAPÊUTICOS DIRECIONADOS AO RECEPTOR DE SOMATOSTATINA SUBTIPO 2 (SST2R) E USOS DOS MESMOS. São descritos aqui terapêuticos direcionados ao receptor de somatostatina subtipo 2 (SST2R) que têm como alvo células tumorais que expressam SST2R e seu uso no tratamento de câncer.
Prosecution history
Publications in the Brazilian Industrial Property Gazette (RPI).
